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Mesenchymal stem cells (MSC) were recently shown to
migrate to injured tissues when transplanted systemically.
The mechanisms underlying the migration and homing of
these cells is, however, unclear. In this study, we examine the
role of CD44 and its major ligand, hyaluronic acid, in the
trafficking of intravenously injected MSC in the
glycerol-induced mouse model of acute renal failure (ARF).
In vitro, hyaluronic acid promoted a dose-dependent
migration of the stem cells that was inhibited by an
anti-CD44 blocking monoclonal antibody. In vivo, stem cells
injected into mice with ARF migrated to the injured kidney
where hyaluronic acid expression was increased. Their
presence correlated with morphological and functional
recovery. Renal localization of the MSC was blocked by
pre-incubation with the CD44 blocking antibody or by
soluble hyaluronic acid. Stem cells derived from CD44
knockout mice did not localize to the injured kidney and did
not accelerate morphological or functional recovery.
Reconstitution by transfection of CD44 knockout stem cells
with cDNA encoding wild-type CD44, but not a loss of
function CD44 unable to bind hyaluronic acid, restored
in vitro migration and in vivo localization of the cells to
injured kidneys. We suggest that CD44 and hyaluronic acid
interactions recruit exogenous MSC to injured renal tissue
and enhance renal regeneration.
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Mesenchymal stem cells (MSC) are multipotent cells present
in bone marrow that can differentiate in vitro into adipocytic,
chondrocytic, and osteocytic lineages.1 In vivo MSC have
been observed not only to regenerate tissues of mesenchymal
lineages2–4 but also to differentiate into neurons5 and
epithelial cells.6–9
Acute renal failure (ARF) associated with nephrotoxic and
ischemic injury is most often the consequence of acute
tubular necrosis.10 The recovery of renal function following
ARF depends on appropriate replacement of necrotic tubular
cells with functional tubular epithelium. Key players in
kidney regeneration include not only mature proliferating
renal cells but also, according to recent reports, stem cells
from local pools as well as from the circulation.11–13 Recent
studies in mouse models of ARF have demonstrated that
MSC display the ability to localize in damaged kidney
promoting both morphological and functional recovery.8,9
However, to date, mechanisms that underlie MSC homing to
injured kidney have not been elucidated.
Tissue injury and inflammation are accompanied by
increased stromal production of the glycosaminoglycan
hyaluronan (HA), which in addition to other functions,
helps to create a low resistance highly hydrated extracellular
matrix that may facilitate local cellular trafficking.14 HA is
also abundantly produced in the bone marrow by both
stroma and hematopoietic cells15,16 and it is implicated in the
regulation of cell–cell and cell–matrix adhesion as well as in
cell proliferation and survival.17,18 The proteoglycan CD44 is
the principal cell surface receptor for HA.19,20 CD44 is a
multifunctional receptor, whose standard isoform is ex-
pressed in hematopoietic stem cells21 and MSC.22 CD44 has
numerous functions, including the regulation of cell
proliferation, differentiation, survival, migration into tis-
sues,20,21 and hematopoietic progenitor trafficking to the
bone marrow and spleen.23–25 Based on these observations,
we addressed the role of CD44 receptor and its ligand HA in
the recruitment of injected MSC in a mouse model of
glycerol-induced ARF.
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RESULTS
Soluble HA induced a chemotactic effect on CD44þ -MSC
MSC, purified from murine bone marrow, express CD44
(Figure 1a). Therefore, we addressed the possibility that the
CD44 ligand HA might have a chemotactic effect on MSC
and promote their migration in vitro. Consistent with this
notion, addition of soluble HA to the lower compartment of
a transwell stimulated migration of MSC through poly-
carbonate filters toward HA (Figure 1b–d). To discriminate
between the chemotactic and the chemokinetic effect of HA
on MSC migration, studies were performed in the presence of
HA on both sides of the Boyden chamber (Table 1). The
migratory effect of HA was related to its gradient, suggesting
chemotaxis rather than chemokinesis. Preincubation of MSC
with a blocking anti-CD44 monoclonal antibody (mAb)
(clone KM114) significantly inhibited HA-induced MSC
migration (Figure 1b and e).
Expression of HA in the renal cortex after
glycerol-induced ARF
Previous work has shown that in normal renal tissue, HA is
detectable predominantly in the medulla and hardly if at all
in the cortex.26 We therefore assessed HA expression in
injured renal tissue following glycerol-induced ARF. Intra-
muscular (i.m.) injection of glycerol induces myolysis and
hemolysis causing toxic and ischemic tubular injury.8 Three
days after glycerol injection, we observed marked tubular
epithelial injury, whereas control mice injected with saline
alone displayed no obvious histological change.8 The lesions
observed in mice with ARF included tubular hyaline cast
formation, vacuolization, and widespread necrosis of prox-
imal and distal tubular epithelium. Proximal tubules showed
cytoplasmic vacuolization, swelling and disorganization of
mitochondria, and loss of the brush border. The injured
cortical renal tissue contained abundant HA deposits along
the tubular basement membrane, whereas no HA was
detectable in normal controls (Figure 2a and b).
Characterization of CD44/- and CD44þ -MSC
In this study, we investigated whether CD44/HA interaction
is instrumental in the localization of exogenous MSC in the
injured kidneys. For this purpose, we obtained and purified
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Figure 1 | HA–CD44 interaction induced in vitro migration of MSC. (a) FACS analysis of CD44þ -MSC showing expression of CD44 in 100% of
cells (10 different MSC preparations were examined with similar results). (b–e) In vitro migration assay of MSC preincubated or not with 5 mg/ml
blocking CD44 mAb (MSC/aCD44) and stimulated with HA. MSC were seeded in the upper side of the transwell, and HA (100 and 200 mg/ml
indicated as 100HA and 200HA) in the lower compartment, as described in Materials and methods. Migration was evaluated after 18 h
incubation at 371C by counting the cells that passed through the 8-mm membrane pores. The filters were fixed and stained with Diff–Quick.
(b) The percentage of increased MSC migration after incubation with HA in respect to control challenged with vehicle alone. Values are expressed
as % with respect to control and are the mean7s.d. of three independent experiments run in triplicate. ANOVA with Newmann–Keuls’
multicomparison test was performed: *Po0.05 MSCþ 100HA and MSCþ 200HA vs vehicle; **Po0.05 MSC/aCD44 þ 100HA and vs
MSCþ 100HA; #Po0.05 MSC/aCD44þ 200HA vs MSCþ 200HA. (c–e) Representative micrographs of MSC migration. Only few MSC migrated to
the lower side of the membrane when challenged with vehicle alone (c); several MSC migrated to the lower side of the membrane when
challenged with 100mg/ml HA (d) but not when preincubated with 5 mg/ml blocking CD44 mAb and challenged with 100mg/ml HA (e).
(Original magnification  200).
Table 1 | Gradient-dependent analysis of HA-induced
migration
Upper chamber
Lower chamber Vehicle 20 lg/ml HA 200 lg/ml HA
Vehicle 13.371.53 22.7711.59 12.372.52
20mg/ml HA 42.371.78 2474.36 10.772.08
200mg/ml HA 44.373.79 21.371.53 13.772.52
Migration of MSC was performed in Boyden chambers by adding HA in the upper
and/or lower compartments to establish positive, negative, absent gradient across
the filter barrier.
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MSC from the bone marrow of CD44/ and CD44þ mice.
CD44/-MSC (at the fourth passage) expressed the
common mesenchymal markers CD105, CD29, CD73 (not
shown) similarly to CD44þ -MSC, but not CD44 (Figure 2c
and d), as assessed by cytofluorimetric analysis. In addition,
MSC from CD44/ and CD44þ mice expressed the stem
cell marker Thy1 (CD90), but not the leukocyte marker
CD45 and CD14 or KDR, a marker of circulating endothelial
progenitor cells (data not shown). Absence of CD34
expression indicated that no contaminating hematopoietic
stem cells were present. No functional differences between
CD44/ and CD44þ -MSC were observed in terms of their
differentiation potential toward adipocytic (Figure 2e and f)
and osteogenic lineages (Figure 2g and h). However, the
growth rate of CD44/ cells was approximately half of that
of wild-type CD44þ -MSC (data not shown), consistently
with the reported role of CD44 in cell proliferation.27
Role of CD44–HA interaction in renal recruitment of MSC
In the glycerol-induced model of acute renal injury, CD44þ
or CD44/-MSC were injected 3 days after glycerol
administration. Twenty-four hours after injection, CD44þ -
MSC were detected within the renal cortex of mice with ARF
by immunoperoxidase staining of carboxy-fluorescein diace-
tate, succinimidyl ester (CFSE)-labelled MSC, by fluorescence
in situ hybridization (FISH) detection of Y chromosome and
by iron detection in iron-dextran-labelled MSC (Figures 3–5).
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Figure 2 | Effect of glycerol-induced tubular injury on HA
expression by renal cortex and characterization of bone
marrow-derived CD44þ -MSC and CD44/-MSC.
(a) Representative micrographs of a cryostat section of renal cortex
from a control mouse killed 3 days after i.m. injection of vehicle alone
showing absence of immunofluorescent staining for HA expression
evaluated with a soluble CD44H-human Ig fusion protein (0.5 mg/ml)
(original magnification  250). (b) Representative micrographs of a
cryostat section of renal cortex of a mouse killed 3 days after i.m.
injection of glycerol showing a positive immunofluorescence staining
along tubular basement membrane and interstitium for HA
expression (original magnification  250). Ten mice were examined
per group with similar results. (c) Representative flow cytometric
analysis of CD44þ -MSC showing the expression of CD44.
(d) Representative flow cytometric analysis of CD44/-MSC showing
that MSC obtained from CD44/ mice were negative for CD44. The
dark line is the test antibody, the dotted line the isotypic control.
(e–f) Representative micrographs of adipogenic differentiation of
CD44þ - and CD44/-MSC detected by the presence of fat droplets.
(g–h) Representative micrographs of osteogenic differentiation
detected by positive staining for calcium deposits using Alizarin Red.
(Original magnification c–f:  250). Ten different cells preparations
were tested with similar results.
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Figure 3 | Role of CD44 in renal homing of MSC in mice with
glycerol-induced ARF. MSC were detected by immunoperoxidase
staining of CFSE or by FISH analysis of Y chromosome 24 h after their
injection. (a–b) Representative micrographs showing the absence
of MSC in renal sections of a mouse without ARF injected with
CD44þ -MSC. (c–d) Representative micrographs showing localization
of MSC in renal sections of a mouse with ARF injected with
CD44þ -MSC. (e–f) Representative micrographs showing the absence
of MSC in renal sections of a mouse with ARF injected with
CD44/-MSC. Original magnification: immunoperoxidase (a, c and e)
 250; FISH analysis (b, d and f; arrows indicate the positive staining
for chromosome Y)  600.
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The labelled cells were observed within peritubular capillaries
and the interstitial space (Figures 3c and d, 4b and c and
5b–d). Few cells were also detected in the glomeruli (Figures
4a and 5a). Very few labelled cells were observed within
tubular epithelium (Figure 4d and 5e). No cells were detected
in control mice without ARF injected with CD44þ -MSC
(Figure 3a and b). In mice with ARF injected with CD44/-
MSC, only rare cells could be detected within the renal cortex
(Figure 3e and f, 4e and f, and 5f). The typical iron inclusions
observed by electron microscopy (Figure 5b and c, insets)
were absent in control ARF mice, suggesting that they were
not due to uptake of iron due to hemolysis. Minimal
localization of MSC was observed in the renal medulla (not
shown), despite the constitutive presence of HA, suggesting
that release of HA fragments by inflammation and of other
factors produced by the injured tissue are required for MSC
recruitment.
To further confirm the role of HA binding by CD44 in the
early localization of MSC in the injured kidney, we
performed reconstitution experiments by transfection of
CD44/-MSC with cDNAs encoding either functional wild-
type CD44 or the CD44R41A mutant, that lacks the ability to
bind the HA (CD44HMut)28 (Figure 6). As expected,
fluorescein isothiocyanate (FITC)-labelled HA bound
CD44þ -MSC but not CD44/-MSC (Figure 6a and b).
Transfection of CD44/-MSC with full-length CD44H
(CD44H MSC) restored their ability to bind HA,
whereas expression of CD44Hmut (CD44HMut MSC)
failed to do so (Figure 6f and g), despite CD44 antigen
expression, as assessed by immunofluorescence (Figure 6c–e).
Migration assay showed that transfection with full-length
CD44H, but not with CD44Hmut, restored chemotaxis to
HA (Figure 6h), suggesting a functional reconstitution
of CD44.
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Figure 4 | MSC detection by light microscopy in mice with glycerol-induced ARF by iron-dextran labelling 24 h after their injection.
(a–d) Representative micrographs showing localization of CD44þ -MSC in renal sections of a mouse with ARF. (a) The presence
of iron-dextran-labelled CD44þ -MSC in a glomerulus (g; arrow) and in peritubular capillaries (arrowheads). (b and c) The concentration of
iron-dextran-labelled CD44þ -MSC around severely damaged tubules containing protein casts. (c) Is a particular of panel (b) clearly showing the
interstitial localization of labelled MSC. (e) Presence of an isolated iron-dextran-labelled CD44þ -MSC (arrow) within a proximal tubule.
(e and f) Absence or presence of a rare iron-dextran-labelled CD44/-MSC (arrow) in renal sections of a mouse with ARF. The sections were
stained with Prussian blue. Original magnification (a, d and e)  400; (c)  600; (b); and (f)  250.
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Figure 5 | MSC detection by electron microscopy in mice with
glycerol-induced ARF by iron-dextran labelling 24 h after their
injection. (a–e) Representative micrographs showing localization of
iron-dextran-labelled CD44þ -MSC in renal ultrathin sections of a
mouse with ARF observed by transmission electron microscopy.
(a) shows the presence of a MSC within the lumen of a glomerular
capillary. The arrow indicates the iron-dextran inclusion. (b–d) show
the presence of iron-dextran-labelled CD44þ -MSC in the peritubular
capillaries (b and c) and in the interstitium. In (c), a cell adherent to
the endothelial layer and a cell infiltrated in the subendothelial space
are shown. Arrows indicate the iron inclusions. The insets in (b and c)
show high magnification of the iron-dextran inclusions. (e) A cell
containing iron-dextran inclusions (arrow) infiltrating a proximal
tubule. (f) The absence of iron-dextran-labelled CD44/-MSC in a
renal section of a mouse with ARF. Original magnification  6000;
insets  25 000.
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As shown in Figure 7, the percentage of labelled MSC
detected in the renal cortex 24 h after injection was
significantly different in mice injected with CD44/-MSC
in respect to CD44þ -MSC. Moreover, CD44H MSC but not
CD44HMut MSC significantly localized in the injured
kidneys (Figure 7a), suggesting that the binding of CD44 to
HA is critical for MSC homing. The role of CD44 in MSC
localization was further confirmed by the inhibition of MSC
localization when pre-incubated with either an anti-CD44
blocking mAb or soluble HA (Figure 7b).
Role of CD44þ -MSC in the recovery of renal injury
Eight days after damage (5 days after MSC injection), an
extensive recovery with regeneration of tubular epithelial cells
and of the cell brush border was observed in mice injected
with CD44þ -MSC (Figure 8a). In contrast, mice injected
with CD44/-MSC displayed persistence of diffuse necrotic
proximal and distal tubule injury (Figure 8c). At day 8, only
scattered CD44þ -MSC were present within the renal
interstitium, whereas the CFSE-labelled and chromosome
Y-labelled cells were mainly detectable within the proximal
tubules (Figure 8b). The number of CFSE-positive MSC
counted in immunoperoxidase-stained sections was
2.270.4% in respect to the total number of counted nuclei.
No CD44/-MSC were detectable at day 8 (Figure 8d). The
morphologic recovery induced by administration of CD44þ -
MSC was accompanied by recovery of the renal function.
Blood urea nitrogen (BUN) levels that peaked at day 3
following ARF induction were significantly reduced at day 8
in the animals that had received CD44þ -MSC (Figure 9a). In
contrast, CD44/-MSC injection did not significantly affect
the BUN levels, that persisted elevated at day 8 as in the
untreated mice (Figure 9a). To evaluate whether the
expression of CD44 affects the severity and the recovery of
glycerol-induced ARF, we compared wild-type and CD44/
mice. As shown by BUN levels, the severity of ARF was
significantly lower in CD44/. However, the increased BUN
persisted at day 8, suggesting that the absence of recruitment
of inflammatory cells in CD44/ mice protected mice from
glycerol-induced ARF (Figure 9b), as previously described for
ischemic injury.29 However, in these animals, a significant
recovery from day 3 to day 8 was not observed as also
inferred by histological analysis (not shown).
To evaluate whether MSC may differentiate into epithelial
cells, the presence of CFSE-labelled CD44þ -MSC expressing
epithelial markers was detected by fluorescence-activated cell
sorter (FACS) analysis in cells obtained from disaggregated
tubular component of renal tissue of ARF mice at day 8. As
shown in Figure 10a, the population of fluorescent CFSE-
positive cells observed in CD44þMSC-treated animals
amounted to 2.370.2% of five experiments. No auto-
fluorescent cell population was detected in control mice
without or with ARF that had not been injected with MSC
(Figure 10a). Co-staining with CFSE and the epithelial
tubular markers, lens culinaris agglutinin, megalin, and
cytokeratin, showed that at least a fraction (respectively,
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Figure 6 | Reconstitution of CD44/-MSC with functional or
non-functional CD44. CD44þ -MSC, CD44/-MSC, and
CD44/-MSC transfected with a full-length CD44 cDNA (CD44H)
or with a mutant form of CD44 cDNA (CD44HMut) transfectant
were generated. (a–d) Representative flow cytometric analysis of
FITC-labelled HA-binding on CD44þ -MSC, CD44/-MSC and
trasfectants. (a and b) The FITC-labelled HA-binding to
(a) CD44þ -MSC but not (b) CD44/-MSC. (c and d) The FITC-labelled
HA-binding to (c) CD44H but not to (d) CD44Hmut. The gray
area is FITC-labelled HA and the dark line is FITC-labelled bovine
serum albumin, used as control. Three different cells preparations
were examined with similar results. (e–g) Representative micrographs
of immunofluorescence analysis with anti-human CD44 (clone
A3D8) mAb of CD44/-MSC transient transfected (e) with an
empty vector, (f) with a full-length CD44 cDNA or (g) with a
mutant form of CD44 cDNA. (Original magnification:  200).
(h) In vitro migration assay of CD44þ -MSC, CD44/-MSC, and
trasfectants. MSC were seeded in the upper side of the transwell,
and HA (100 mg/ml) in the lower compartment, as described in
Materials and methods. Migration was evaluated after 18 h
incubation at 371C by counting the cells that passed through
the 8-mm membrane pores. The filters were fixed and stained
with Diff–Quick. Data show the percentage of increased MSC
migration after incubation with HA in respect to control
challenged with vehicle alone. Values are expressed as % with
respect to control and are the mean7s.d. of three independent
experiments run in triplicate. ANOVA with Dunnett’s
multicomparison test was performed *Po0.05 MSC stimulated
with HA vs MSC stimulated with vehicle.
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26.2%79.65, 21.0%76.08, 64.2%717.28 of five experi-
ments) of CFSE-positive cells recovered from the kidney
expressed epithelial differentiation markers (Figure 10b).
Before injection, MSC did not express any of these epithelial
markers (Figure 10b). When CFSE-labelled CD44/-MSC
were injected in ARF mice, only very few fluorescent cells
were detected (Figure 10a). To evaluate whether MSC fused
with epithelial cells in the kidney, we studied the DNA
content of the CFSE-positive population by FACS analysis. As
shown in Figure 10c, the CFSE-positive cells showed a ploidy
of 2N, rather than 4N, indicating that a significant fusion did
not occur.
DISCUSSION
Migration towards sites of tissue injury is the first step of
stem cell-mediated tissue regeneration. Homing of MSC into
injured tissues relies upon their ability to migrate to and
interact with the local microenvironment in a manner that
secures their anchorage at sites where their effector functions
are required.
We have shown here that expression of cell surface CD44
is involved in the localization of exogenous MSC to injured
renal tissue based on the observations that loss of CD44
expression by MSC or expression of a CD44 loss-of-function
mutant results in ineffective MSC localization to injured
tissue and inhibition of renal repair.
Several studies suggest that MSC may contribute to the
recovery of acute tubular injury.8,9,30 It remains however
uncertain whether bone marrow-derived stem cells may be a
source of regenerating tubular cells or rather contribute to
tubular recovery by a mechanism of protection.31 Indepen-
dently from the mechanism involved in renal repair, the local
recruitment of MSC is a condition necessary for their
beneficial effect.31 Currently, little is known about the
molecular mechanisms that underlie MSC recruitment.
Recent studies suggest that triggering of the chemokine
receptor CXCR4 by its ligand stromal derived factor may play
an important role in the migration of transplanted MSC to
sites of injury in the brain,32 even though CXCR4 appears to
be expressed at a low level on the surface of MSC.33 Although
it is likely that several mechanisms, including chemokine–-
chemokine receptor interactions and possibly several adhe-
sion receptor-ligand pairs, participate in MSC homing,
CD44–HA interaction may provide a dominant force in
guiding MSC to appropriate repair/regeneration sites. The
importance of CD44-mediated cell interaction with HA for
the regulation of cell migration has been shown in several
biological processes, including inflammation and tumor
metastasis.34–39 Recently, it has been shown that CD44–HA
interaction is involved in MSC migratory capacity.37 In line
with this study, we found that HA-mediated in vitro
migration of MSC is prevented by preincubation with an
anti-CD44 blocking Ab or soluble HA. HA, the principal
CD44 ligand,19 has been suggested to drive recruitment of
hematopoietic stem and progenitor cells to the bone
marrow.23,24 However, the potential role of CD44 in MSC
homing to injured tissue had so far not been addressed. HA is
barely detectable in many normal tissues in the resting state
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Figure 7 | Localization of CD44þ -MSC but not CD44/-MSC in kidneys of mice with ARF 24 h after injection. CD44þ -MSC, CD44/-MSC,
and CD44/-MSC transfected with a full-length CD44 cDNA (CD44H) or with a mutant form of CD44 cDNA (CD44HMut) transfectant were
generated and injected in ARF mice. (a) count of CFSE-labelled MSC within renal tissue of control mice without ARF or of mice with
glycerol-induced ARF that were injected with CD44þ -MSC, CD44/-MSC, or CD44H MSC or CD44HMut MSC evaluated 24 h after injection. The
number of CFSE-positive MSC was counted in 10 non-sequential sections for each experiment at  200 magnification and expressed as % in
respect to the total number of counted nuclei. Data are expressed as mean count7s.d. of CFSE-labelled MSC detected by immunohistochemical
staining of 12 different mice. ANOVA with Newmann–Keuls’ multicomparison test was performed: #Po0.05 ARFþCD44H MSC vs CD44H MSC
without ARF and ARFþCD44þ -MSC vs CD44þ -MSC without ARF; 1Po0.05 ARFþCD44/-MSC vs ARFþCD44þ -MSC; *Po0.05
ARFþ CD44HMut MSC vs ARFþ CD44H MSC. (b) Reduction of the renal localization of CD44þ -MSC 24 h after injection when cells were preincubated
for 30 min with 5 mg/ml blocking CD44 mAb (MSC/aCD44) or with 200 mg/ml soluble HA (MSC/HA). Data are expressed as mean count7s.d.
of CFSE-labelled MSC detected by immunohistochemical staining in 10 fields per kidney of three different mice. ANOVA with
Newmann–Keuls’ multicomparison test was performed: *Po0.05 ARFþMSC vs MSC; **Po0.05 ARFþ MSC/aCD44 vs ARFþMSC;
#Po0.05 ARFþ MSC/HA vs ARFþMSC.
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and, whereas it is abundant in the renal medulla, it is virtually
absent from the cortex of normal kidney.26 However, tissue
remodelling associated with development, inflammation,
repair, and cancer invasion is accompanied by robust
induction of stromal HA production and deposition.
Accordingly, 3 days after induction of ARF by glycerol
injection, HA deposition was readily detectable in the
interstitium and along the tubular basement membrane in
renal cortex. Similar observations have been made following
induction of ischemia-reperfusion injury.40
The migratory effect of soluble HA on MSC that we
observed in this study was related to its gradient, suggesting a
chemotactic mechanism. During injury, it is conceivable that
protease-induced matrix degradation may release soluble HA
fragments that may contribute to the recruitment of MSC.
In this study, we demonstrate that localization of
exogenous MSC to injured renal tissue is dependent on the
CD44–HA interaction. The CD44þ -MSC were detectable
within peritubular vessels and the interstitium 24 h after
injection, consistent with other studies that demonstrated the
early recruitment of MSC to the kidney.41 In contrast, MSC
derived from CD44/ mice failed to localize to the injured
tissue. Disruption of CD44/HA interaction by pre-incubation
with anti-CD44 mAb or soluble HA confirmed the relevance
of a functional CD44 for MSC recruitment. Indeed,
transfection of CD44/ MSC with functional CD44, but
not with a CD44 loss-of-function mutant, restored the
recruitment of MSC. This result, together with experiments
of CD44 blockade, indicates that CD44 has a critical role in
the localization of exogenous MSC in the kidney. However,
we cannot exclude that extrarenal events may contribute to
the reduced renal accumulation of CD44/ cells.
The recruitment of MSC within the injured kidney
accelerated the functional and morphological recovery. Using
whole-bone marrow transplantation in the mouse, Poulsom
et al.42 demonstrated that bone marrow-derived cells could
contribute to regeneration of the renal tubular epithelium. It
is debated whether bone-marrow-derived stem cells con-
tribute to renal recovery by fusion or transdifferentiation into
tubular epithelial cells. Duffield et al.43 showed that bone
marrow does contain cells capable of protecting the kidney
from ischemic injury, but these cells were not directly
incorporated into the repaired tubules. Lin et al.44 found that
only a minority of bone marrow-derived cells were
incorporated into the injured tubules as epithelial cells.
Broekema et al.45 demonstrated that the tubular engraftment
of bone marrow-derived cells depends on the severity of renal
damage after ischemia/reperfusion injury and that once
engrafted these cells acquire an epithelial phenotype. The
results of this study showed that after 24 h, the injected MSC
were mainly detectable within the peritubular capillaries and
interstitium, whereas after 8 days MSC were found mainly
within tubules. The experiments with CFSE-labelled MSC
followed by their recovery from the tissue indicate that about
2–2.5% of the cells recovered from the renal cortex at day 8
derived from the injected MSC. Fang et al.46 found some
evidence for cell fusion between resident renal tubular cells
and bone marrow-derived cells, but this was infrequent and
the significance and consequences of cell fusion in the kidney
are still unclear. In this study, we found that CFSE-positive
cells showed a ploidy of 2N rather than 4N, suggesting that a
significant fusion did not occur. Moreover, the number of
MSC detectable in the renal injured tissue was not increased
at 8 days in respect to the 24 h, suggesting a minor role of
MSC in the repopulation of tubules. These data are consistent
with a previously reported prominent role of proliferation of
resident cell in the repopulation of tubules.43–46 Owing to
their low number, the repopulation of tubules cannot be
ascribed to the transdifferentiation of the injected MSC but
rather to a beneficial paracrine effect. MSC may favor de-
differentiation and proliferation of the surviving tubular cells
or stimulation of resident stem cells.11,31 Moreover, MSC
possess an anti-inflammatory31 and immunosuppressive
potential47,48 that may be involved in the protection of tissue
injury. On the other hand, the ability of bone-marrow-
derived stem cells to transdifferentiate and contribute to
a
c d
b
Figure 8 | Role of CD44þ -MSC in morphological renal recovery in
mice 8 days after ARF induction. Micrographs are representative
of glycerol-induced acute tubular injury after CD44þ -MSC and
CD44/-MSC injection. (a and b) Morphological recovery of renal
damage and CD44þ -MSC renal localization in mice with ARF injected
i.v. with 1 106 CD44þ -MSC 3 days after receiving the i.m. injection
of glycerol and killed 5 days after the MSC administration (day 8).
Representative micrographs of a light microscopy section stained
with haematoxylin eosin (a: original magnification  250) and of
electron microscopy (inset: original magnification  4000) showing
the recovery of tubular injury. (b) Detection of CFSE-labelled
CD44þ -MSC by immunohistochemistry (original magnification
 250) and by detection of Y chromosome by FISH (inset: original
magnification  600) showing the presence of CFSE-positive and Y
chromosome-positive cells within some tubules (arrows; T¼ tubule).
(c and d) morphological alterations and CD44/-MSC renal
localization in mice with ARF injected i.v. with 1 106 CD44/-MSC
3 days after receiving the i.m. injection of glycerol and killed 5 days
after the MSC administration (day 8). Representative micrographs of a
light microscopy section stained with haematoxylin eosin (c: original
magnification  250) and of electron microscopy (inset: original
magnification  4000) showing the persistence of severe tubular
injury. (d) Absence of localization of CFSE-labelled CD44/-MSC by
immunohistochemistry (i: original magnification  250). Twelve mice
were examined per group with similar results.
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podocyte regeneration has been recently shown in a murine
model of Alport syndrome.49,50
Tissue injury of a broad range of etiologies is associated
with HA overproduction and CD44 is not only functional in
MSC but it is expressed in most leukocyte populations.
Therefore, CD44 may also provide a mechanism for
leukocyte recruitment to sites of injury with potentially
detrimental consequences.29 This is consistent with the
finding that CD44/ mice are protected from ischemic
renal injury29 and, as observed herein, from glycerol-induced
ARF. The reduced severity of ARF possibly depends on the
inhibition of the recruitment of inflammatory cells. The
results of this study indicate that therapeutic administration
of exogenous MSC takes advantage of the same molecular
mechanism involved in the accumulation of the inflamma-
tory cells within the kidney for their localization at the site of
tissue injury. However, it is unclear whether endogenous
MSC exploit CD44/HA interaction in the localization at the
site of injury.
Taken together, our observations have uncovered an
essential role of CD44-mediated HA binding in the recruit-
ment to injured renal tissue of injected exogenous MSC
leading to an enhanced renal regeneration.
MATERIALS AND METHODS
Mice
Adult CD44 knockout mice (CD44/) on C57BL/6 background
(Cd44tm1Hbg/J),51 and adult F2 Hybrid mice (C57BL/6J, 129S1/
SvImJ) were purchased from Jackson Laboratory (Bar Harbor, MI,
USA). Studies were conducted in accordance with the National
Institute of Health Guide for the Care and Use of Laboratory
Animals.
Isolation and culture of MSC
CD44þ -MSC and CD44/-MSC from femurs and tibias of
8-week-old mice were obtained as described previously.52 Cells
had a typical spindle-shaped appearance, and the MSC phenotype
was confirmed by expression of MSC markers and by ability to
differentiate into osteocytes and adipocytes, as described.1
Cell migration assay
Twenty-four transwell units were used for monitoring in vitro cell
migration using 8-mm pore polycarbonate filters (CoStar Corp.,
Cambridge, MA, USA) as described previously.53 CD44þ -MSC
(5 104 cells/well in a-minimum essential medium (a-MEM)),
untreated or treated previously for 30 min at 371C with the blocking
rat anti-mouse CD44 mAb (5mg/ml, clone KM114) (Becton
Dickinson, San Jose, CA, USA)54 were placed in the upper chamber
of the transwell unit. a-MEM with 200 or 100 mg/ml HA (from
Rooster comb; Sigma, St Louis, MO, USA) was placed in the lower
chamber of the transwell unit. CD44þ -MSC were allowed to
migrate for 18 h through the membrane pores. In selected
experiments, different combinations of HA (20 and 200mg/ml)
were added above and below the transwell membrane.
CD44/-MSC transient transfection
Transient MSC transfectants were generated by electroporation at
250 V and 900 mF in 4 mm electroporation cuvettes in a BIO-Rad
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Figure 9 | Evaluation of renal function in wild-type mice injected with CD44þ or CD44/-MSC, and in CD44/ mice 3 and 8 days after
glycerol-induced ARF. (a) Evaluation of BUN in CD44þ -MSC, CD44/-MSC, and MSC untreated mice before, 3 and 8 days after glycerol
injection. MSC (arrows) were injected at day 3. Injection of CD44þ -MSC but not of CD44/-MSC enhanced the recovery of the renal function.
Each group consisted of 12 mice. Data are expressed as mean7s.d. and ANOVA with Newmann–Keuls’ multicomparison test was
performed: *Po0.05 ARFþ CD44þ -MSC vs ARFþ CD44/-MSC. (b) Comparison of the BUN levels in wild-type (wt) or CD44/ mice before,
3 and 8 days after glycerol injection. The increase of BUN in CD44/ mice was significantly lower then in wild-type mice at day 3. At day 8, the
spontaneous recovery was significant in wild-type mice but not in CD44/ mice. Each group consisted of 12 mice. Data are expressed as
mean7s.d. and ANOVA with Newmann–Keuls’ multicomparison test was performed: *Po0.05 ARF CD44/ mice vs ARF wt mice; #Po0.05
day 8 vs day 3.
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Figure 10 | FACS analysis of CFSE-labelled MSC recovered from renal tissue of ARF mice. (a) Column 1: representative flow cytometric
analysis of renal cells derived at day 8 from ARF mouse injected with CFSE-labelled CD44þ -MSC showing the presence of a population (2.5%) of
fluorescent CFSE-positive cells (FITC). Cytokeratin staining (PE) showed that almost all of the CFSE-positive cells were also cytokeratin positive.
Column 2 and Column 3: representative flow cytometric analysis of renal cells derived from control mouse without (Column 2) or with ARF
(Column 3) injected with vehicle alone, showing no auto-fluorescent cell population. Cytokeratin (PE) was more expressed in cells from healthy
mice than in ARF mice, owing to cell damage; no double positive (PE and FITC) cells were detectable. Column 4: representative flow cytometric
analysis of renal cells derived from ARF mouse injected with CFSE-labelled CD44/-MSC showing that only very few fluorescent cells were
detectable. Cytokeratin staining (PE) showed that in mice injected with CFSE-labelled CD44/-MSC only few double-positive cells were
detectable. The isotypic controls show the absence of PE auto-fluorescent cells. Five experiments were performed. (b): representative flow
cytometric analysis of the expression of epithelial markers by CD44þ -MSC before and after the injection in ARF mice. In basal condition, MSC
did not express the epithelial tubular markers lens culinaris agglutinin, megalin, and cytokeratin. Eight days after ARF the CFSE-positive cells
(gate) showed co-staining with the epithelial tubular markers lens culinaris agglutinin, megalin, and cytokeratin, indicating that at least a
fraction of CFSE-positive cells expressed epithelial differentiation markers. Five experiments were performed. (c) DNA analysis of cells derived at
day 8 from ARF mouse injected with CFSE-labelled CD44þ -MSC or vehicle. CFSE-positive cells present in ARF mice treated with MSC showed a
2N DNA content. Three experiments were performed with similar results.
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Gene-Pulser II Electroporation System (Bio-Rad, Hercules, CA,
USA) with 30 mg of the pCDM8 plasmid vector containing
full-length CD44H cDNA or CD44R41A mutant of CD44H
(CD44HMut) that cannot bind HA.28 Cells were then plated and
used for experiments 72 h after transfection. Transfection efficiency
was similar for both constructs ranging between 25 and 30%
positive cells by immunofluorescence.
Murine model of ARF and MSC transplantation
To evaluate the ability of CD44þ -MSC, CD44/-MSC and
transfected CD44/-MSC to localize into injured kidney, we
induced ARF by i.m. injection of glycerol (Sigma) 7.5 ml/kg8 and,
3 days after glycerol injection, MSC were intravenously (i.v.) injected
into the tail vein. CD44þ -MSC, pre-incubated with either an anti-
CD44 blocking mAb (KM114, 5 mg/ml) or soluble HA (200 mg/ml)
before injection, CD44/-MSC and transfected CD44/-MSC
(passage III–IV) were harvested using non-enzymatic cell dissocia-
tion solution (Sigma). MSC were labelled with 10 mM of CFSE that
reacts with the intracellular ammines forming fluorescent conjugates
(Vybrant cell tracer kit, Molecular Probes, Eugene, OR, USA) by
incubation in a-MEM for 30 min as described previously.41 In
selected experiments, MSC were labelled for 24 h with carboxy-
dextran-coated iron oxide nanoparticles (Resovist, Schering,
Berlin, Germany).30 MSC were counted, resuspended in a-MEM
(1 106 in 150ml a-MEM) and i.v. injected in glycerol-treated
and untreated animals. Mice were killed 24 h or 5 days after
transplantation. Localization of iron-labelled MSC was studied
only at 24 h because in preliminary experiments, we found that
after 3 days iron is dismissed form MSC and can be captured
by tubular cells. As control, female mice were injected i.v. with
saline 3 days after the glycerol injection. Injected cells were identified
using immunohistochemistry with an anti-CFSE polyclonal Ab
(pAb), FISH (see below), or Prussian blue to identify iron-loaded
cells.30
Immunofluorescence, FITC-labelled HA-binding assay and
immunohistochemistry
Cytofluorimetric analysis was performed as described.8. The
following Abs were used: anti-CD105, -CD29, -CD73, -CD34,
-CD45, -CD14, -Thy1 mAbs (Becton Dickinson); anti-CD44 mAb
(clone KM114); anti-cytokeratin mAb (Biomeda, Foster City, CA,
USA), anti-KDR mAb (Chemicon, Temecula, CA, USA), anti-
megalin pAb (Santa Cruz Biotechnology, Santa Cruz, CA, USA),
lens culinaris agglutinin (Vector Laboratories Inc., Burlingame, CA,
USA); phycoerythrin (PE)-conjugated goat against rat immunoglo-
bulin G (IgG) (Sigma) pAb, PE-goat against mouse IgG and against
rabbit IgG (DakoCytomation, Copenhagen, Denmark), and PE-
rabbit against goat IgG (Santa Cruz) pAbs. The analysis was
performed using a FACSCalibur cytometer (Becton Dickinson). A
minimum of 10 000 cells were collected for all analyses. CFSE-
labelled MSC were detected by FACS analysis after dissociation of
the tubular fraction deprived of glomeruli as described previously.11
For binding studies, cells were incubated with FITC-labelled HA
or FITC-labelled bovine serum albumin at 5 mg/106 cells, as
described.55 For HA detection, kidney sections were incubated with
soluble CD44H-human Ig fusion protein (0.5 mg/ml) prepared as
described19 or human IgG1 isotypic control Ab for 2 h, washed in
phosphate-buffered saline and incubated with the FITC-conjugated
goat antihuman IgG pAb (Sigma) (1:1000) at 221C for 30 min.56
Immunofluorescence on transfected cultured MSC was performed
using the antihuman CD44 (clone A3D8) mAb (Sigma). Ethidium
bromide (Sigma) was used for nuclear counterstaining. Immuno-
histochemistry for MSC labelled with CFSE (Molecular Probes) in
injured kidney was conducted using an anti-fluorescein/Oregon
green pAb (Molecular Probes), as described.41 The number of CFSE-
positive MSC was counted in 10 non-sequential sections for each
experiment at magnification  200 and expressed as % in respect to
the total number of counted nuclei.
DNA content of engrafted cells
The analysis of DNA content of kidney-migrated CFSE-labelled
MSC was performed as described.57 Briefly, isolated cells were
washed in phosphate-buffered saline before 15 min fixation in 4%
paraformaldehyde, followed by a fixation in cold acetone for other
15 min. Thereafter, cells were washed in phosphate-buffered saline/
bovine serum albumin and were incubated for 2 h at 41C with
propidium iodate (50 mg/ml) (Sigma) to stain the DNA in a solution
containing RNAse (200 mg/ml) (Sigma) and 0,1% Tween 20. Cells
samples were analyzed on a FACScan (Becton Dickinson).
Fluorescence in situ hybridization
Paraffin kidney sections were hybridized with a Starfish Cy3-labeled
mouse Y chromosome paint (Star-FISH; Cambio, Cambridge, UK)
as previously described.42 After denaturation at 601C, slides were
incubated with the denatured probe at 371C overnight, and
posthybridization was performed at 371C by three rinses with 50%
formamide/ 2 SSC and then  0.1 SSC followed by phosphate-
buffered saline. Nuclei were counterstained with Hoechst 33258 dye
(Sigma). Images were taken with a Confocal microscope (Carl Zeiss
International, Germany).
Morphological studies
Transmission electron microscopy was performed on Karnovsky’s-
fixed, osmium tetraoxide-postfixed tissues and embedded in epoxy
resin according to standard procedures.58 Ultra-thin sections were
stained with uranyl acetate and lead citrate and were examined with
a Jeol JEM 1010 electron microscope.
BUN
Blood samples from different groups were collected. Renal function
was assessed as BUN in heparinized blood using a on a Beckman
Synchrotron CX9 automated chemistry analyzer (Beckman Instru-
ments Inc., Fullerton, CA, USA).
Statistical Analysis
Statistical analysis was performed by using the analysis of variance
(ANOVA) with Newmann–Keuls’multicomparison test. A P-value of
o0.05 was considered significant.
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